Bengaluru Startup Takes Cancer Diagnostics to the Next Level: Transforming Early Disease Detection.
Bengaluru is seeing a major advancement in medical diagnostics as Quantum Biosciences Private Limited, a deep-tech startup, is in the forefront of using quantum technology to identify tissue damage and cellular damage before symptoms appear. This cutting-edge “predictive tech” could transform early diagnosis in a number of medical specialties and promises a “quantum” jump in cancer care.
Also Read About Fujitsu Quantum computers With 10000+ superconducting Qubits
Using Quantum Biosensors to Gain Unprecedented Knowledge
Detecting distinct ‘magnetic fingerprints’ of oxidative stress within cells is the main breakthrough of Quantum Biosciences’ quantum biosensor. By detecting these particular magnetic signals, the technique can identify tissue damage at a remarkably early stage, as oxidative stress is a major predictor of cellular damage. Quantum Biosciences seeks to uncover issues in a matter of hours, potentially altering the course of patient outcomes, in contrast to traditional diagnostic methods like MRI, PET scans, and blood biomarkers, which only detect injury after substantial damage has already occurred.
According to Quantum Biosciences Managing Director Ravi Puvvala, current diagnostic techniques frequently fail to provide early warnings. It clarified that current diagnostic methods, like blood biomarkers, MRIs, and PET scans, only identify damage after it has already caused substantial harm. This early detection skill could greatly increase therapy efficacy and lower long-term consequences, and it is essential for prompt action.
Quantum biosensors
Bengaluru-based deep-tech startup Quantum Biosciences Private Limited is developing a state-of-the-art “predictive tech” called quantum biosensors.
These are a few essential features of quantum biosensors.
Mechanism of Detection
- They are made to identify distinct oxidative stress “magnetic fingerprints” in cells. One important marker of cellular damage is oxidative stress. This method seeks to detect these particular magnetic signatures in order to diagnose tissue damage at a remarkably early stage.
- To do this, quantum biosensors make use of quantum technology.
- They are designed to identify quantum-level events such as magnetic biomarkers and subcellular free radicals.
- The main objective is to identify tissue injury and cellular damage before symptoms manifest.
Objective and Use in Healthcare
- This “quantum leap” has the potential to transform cancer care by advancing early detection.
- It seeks to give detection in a matter of hours, which could revolutionise patient outcomes.
- In particular, it could anticipate radiation-induced cardiotoxicity and other chronic issues before irreparable harm is done, which is motivated by Quantum Biosciences Managing Director Ravi Puvvala’s own experience.
- Once the fundamental mechanism is mastered, the method may have applications outside oncology, including nephrology (diseases of the kidneys), cardiovascular disease, and neurodegenerative disorders.
Also Read About Quantum Flag Qubits Improve Quantum Circuit Error Correction
A Personal Motivation Fuels Innovation
For Ravi Puvvala, the origins of this revolutionary invention are very personal. It was inspired by seeing their spouse suffer while undergoing cancer treatment. The woman received radiation therapy following her diagnosis, which is a necessary cancer treatment but regrettably kills both healthy and diseased cells. Serious long-term consequences result from this non-discriminatory damage, such as exhaustion, cognitive loss, organ failure, secondary malignancies, and even ailments like fibrosis or heart disease. Puvvala observed his spouse suffer from these adverse consequences.
After 15 years of developing sensors, mostly for the automotive sector, Puvvala aimed to use that expertise to address this pressing medical issue. Before irreparable heart damage occurred, that started investigating the prospect of employing sensors to forecast radiation-induced cardiotoxicity. The investigation of quantum sensors for early diagnoses was ultimately a result of this individual pursuit.
Strategic Partnerships and Platform Technology
The partnership between Puvvala and QT Sense, a Netherlands-based business run by another Indian, Deepak Veeragowda, marked a “quantum leap” in Quantum Biosciences‘ development. In order to commercialize 15 years of scholarly study in this area carried out at the University of Groningen, QT Sense was established.
The partnership makes use of Quantum Nuova from QT Sense, a powerful platform technology designed especially for identifying occurrences at the quantum level. This involves the detection of magnetic biomarkers and subcellular free radicals, which are essential components of Quantum Biosciences’ methodology. “It’s have been investigating different potential technologies for early stage diagnostics for the past two years,” Puvvala said. It examined both quantum and classical sensors, and in order to take use of quantum sensors’ potential, one can began developing quantum biosensors.
Also Read About Quantum Sensing Applications Nears Industry Marketing
The Path Forward: Validation and Collaboration
Although subcellular stress may presently be detected by quantum biosensors, interpreting these results is a critical next step. In order to provide precise prognoses, Puvvala underlined the necessity of more study to link cellular stress to certain biomarkers. Ultimately added more study is needed to map cellular stress to a biomarker; only then can a diagnosis be made.
The business understands the need for thorough subcellular detection validation. “It’s able to actually go inside the cell and measure all kinds of things for the first time,” Puvvala added. likewise must now use clinical testing to interpret the meaning of these measurements. Therefore, one must be able to develop a diagnostic system and perform tests. In order to accomplish this, Quantum Biosciences intends to work with a number of institutions in India and abroad over the course of the next two years. In particular, it will look to form alliances with cancer centers in order to collect vital data.
“It’s need a whole village to build this technology,” Puvvala said, emphasizing the need for teamwork. Everyone require the medical and engineering teams, as well as individuals like us who can integrate all of this. The Centre for Cellular and Molecular Platforms (C-CAMP), a project of the Department of Biotechnology, Ministry of Science and Technology, Government of India, is where Quantum Biosciences is presently developing its fundamental research skills.
Additionally, they are held at the Indian Institute of Science (IISc), Bengaluru, at the Centre for Nano Science and Engineering (CeNSE). They are also collaborating with state-level innovation initiatives and other ecosystem players to create a common architecture that connects clinical applications and deep-science research.
Wider Effects on Indian and International Healthcare Beyond oncology, Quantum Biosciences’ technology has far-reaching consequences. According to Puvvala, the technique may potentially help with nephrology (diseases of the kidneys), cardiovascular disease, and neurodegenerative disorders once the “very base-level mechanism” is mastered.
Additionally, this invention has a lot of potential to solve India’s basic healthcare issues. Puvvala brought out a prevalent problem: “One of the things that was mentioned at the conference is that most hospitals are overcrowded because the primary health care and the critical health care have been combined into one” . By accurately detecting instances that need critical care in a significantly shorter amount of time, the quantum biosensor may reduce the strain on primary healthcare.
At the just-completed Quantum India Bengaluru Summit, where Puvvala actively engaged with researchers and important stakeholders, including government officials, academic institutions, clinicians, pharmaceutical companies, and hospitals, Quantum Biosciences was one of more than 20 exhibitors. In the future, diseases will be able to be identified and treated earlier than before to this groundbreaking breakthrough.
Also Read About The Argonne National Laboratory News For Quantum Material
